These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6626415

  • 1. The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man.
    Houin G, Brunner F, Nebout T, Cherfaoui M, Lagrue G, Tillement JP.
    Br J Clin Pharmacol; 1983 Sep; 16(3):245-52. PubMed ID: 6626415
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of cerivastatin in renal impairment are predicted by low serum albumin concentration rather than by low creatinine clearance.
    Vormfelde SV, Mück W, Freudenthaler SM, Heyen P, Schmage N, Kuhlmann J, Müller GA, Gundert-Remy UM, Gleiter CH.
    J Clin Pharmacol; 1999 Feb; 39(2):147-54. PubMed ID: 11563406
    [Abstract] [Full Text] [Related]

  • 3. The effect of renal disease on the pharmacokinetics of diethylcarbamazine in man.
    Adjepon-Yamoah KK, Edwards G, Breckenridge AM, Orme ML, Ward SA.
    Br J Clin Pharmacol; 1982 Jun; 13(6):829-34. PubMed ID: 7093114
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of alfentanil in chronic renal failure.
    Chauvin M, Lebrault C, Levron JC, Duvaldestin P.
    Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599
    [Abstract] [Full Text] [Related]

  • 5. The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA, Johnson GE, Endrenyl L, Kelly MF, Fenton SS.
    Scand J Infect Dis Suppl; 1976 Jan; (9):24-31. PubMed ID: 1070145
    [Abstract] [Full Text] [Related]

  • 6. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM, Kumana CR, Franklin DA, Baker LR.
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of ketoprofen in patients with chronic renal failure.
    Stafanger G, Larsen HW, Hansen H, Sørensen.
    Scand J Rheumatol; 1981 Jul; 10(3):189-92. PubMed ID: 7291952
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of disopyramide in patients with chronic renal failure.
    Francois B, Mallein R, Rondelet J, Lussignol M.
    Eur J Drug Metab Pharmacokinet; 1983 Jul; 8(1):85-92. PubMed ID: 6861798
    [Abstract] [Full Text] [Related]

  • 9. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP, Houin G, Ledudal P, Cautreels W, Giudicelli CP, Tillement JP.
    Int J Clin Pharmacol Res; 1984 Jul; 4(3):165-73. PubMed ID: 6149194
    [Abstract] [Full Text] [Related]

  • 10. Ketanserin pharmacokinetics in patients with renal failure.
    Barendregt JN, Van Peer A, Van Der Hoeven JG, Van Oene JC, Tjandra YI.
    Br J Clin Pharmacol; 1990 Jun; 29(6):715-23. PubMed ID: 2378791
    [Abstract] [Full Text] [Related]

  • 11. Serum concentration and urinary excretion of doxycline in normal subjects and patients with renal insufficiency.
    Ao NK, Taneja OP, Bhatia VN, Aggarwal DS.
    Chemotherapy; 1974 Jun; 20(3):129-40. PubMed ID: 4854258
    [No Abstract] [Full Text] [Related]

  • 12. [Doxycycline pharmacokinetics in chronic kidney failure patients treated by hemodialysis].
    Słuczanowski W.
    Ann Acad Med Stetin; 1981 Jun; 27():313-30. PubMed ID: 7345952
    [No Abstract] [Full Text] [Related]

  • 13. Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.
    Snoeck E, Van Peer A, Sack M, Horton M, Mannens G, Woestenborghs R, Meibach R, Heykants J.
    Psychopharmacology (Berl); 1995 Dec; 122(3):223-9. PubMed ID: 8748391
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency.
    Rovei V, Campistron G, Dueymes JM, Ego D, Conte JJ, Houin G.
    Eur J Clin Pharmacol; 1987 Dec; 33(3):303-10. PubMed ID: 3691618
    [Abstract] [Full Text] [Related]

  • 15. Acebutolol pharmacokinetics in renal failure.
    Smith RS, Warren DJ, Renwick AG, George CF.
    Br J Clin Pharmacol; 1983 Sep; 16(3):253-8. PubMed ID: 6626416
    [Abstract] [Full Text] [Related]

  • 16. [The pharmacokinetics of doxycycline in kidney insufficiency in geriatric patients compared to younger adults].
    Simon C, Malerczyk V, Engelke H, Preuss I, Grahmann H, Schmidt K.
    Schweiz Med Wochenschr; 1975 Nov 29; 105(48):1615-20. PubMed ID: 1215947
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH, Knupp CA, Forgue ST, Matzke GR, Guay DR, Pittman KA.
    Clin Pharmacol Ther; 1990 Sep 29; 48(3):268-76. PubMed ID: 2401125
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.
    Ohkawa M, Nakashima T, Shoda R, Ikeda A, Orito M, Sawaki M, Sugata T, Shimamura M, Hirano S, Okumura K.
    Chemotherapy; 1985 Sep 29; 31(6):410-6. PubMed ID: 3908006
    [Abstract] [Full Text] [Related]

  • 19. Sotalol kinetics in renal insufficiency.
    Blair AD, Burgess ED, Maxwell BM, Cutler RE.
    Clin Pharmacol Ther; 1981 Apr 29; 29(4):457-63. PubMed ID: 7471612
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and plasma steady state levels of doxycycline in undernutrition.
    Raghuram TC, Krishnaswamy K.
    Br J Clin Pharmacol; 1982 Dec 29; 14(6):785-9. PubMed ID: 7150457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.